Publications of Yvonne Genzel

Nikolay, A., Genzel, Y., Schwamborn, K., Leon, A., & Reichl, U. (2018)Flavivirus production in perfusion processes using the EB66® cell lineIn: Vaccine Technology VII, 80.

Wu, Y., Liu, X., Tan, W.-S., Bissinger, T., Genzel, Y., & Reichl, U. (2018)Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined mediumIn: Vaccine Technology VII, 5.

Tapia, F., Genzel, Y., Reichl, U., & Sandig, V. (2017)Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccinesIn: ECI Symposium Series.

Fernandes, P., Castro, R., Laske, T., Genzel, Y., Kremer, E., Alves, P., & Coroadinha, A. (2014)The impact of MDCK cell source on the production of influenza and canine adenovirusIn: New Biotechnology: Abstracts of the 16th European Congress on Biotechnology, S180doi: 10.1016/j.nbt.2014.05.907.

Janke, R., Genzel, Y., Wetzel, M., & Reichl, U. (2011)Effect of influenza virus infection on key metabolic enzyme activities in MDCK cellsIn: BMC Proceedings, P129doi: 10.1186/1753-6561-5-S8-P129.

Roedig, J., Rapp, E., Genzel, Y., & Reichl, U. (2011)Impact of different influenza cultivation conditions on HA N-glycosylationIn: BMC Proceedings, P113doi: 10.1186/1753-6561-5-S8-P113.

Vester, D., Rapp, E., Kluge, S., Genzel, Y., & Reichl, U. (2010)Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von ProduktionszelllinienIn: Chemie Ingenieur Technik, 1496doi: 10.1002/cite.201050197.

Öncül, A., Kalmbach, A., Genzel, Y., Reichl, U., & Thevenin, D. (2009)Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-BioreaktorenIn: Chemie-Ingenieur-Technik, 1241 doi: 10.1002/cite.200950096.

Sidorenko, Y., Dauner, M., Genzel, Y., & Reichl, U. (2006)Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture MediaIn: Metabolic Engineering VI: Program, 102.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Kershaw, O., Volckmar, J., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo EfficacyPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Genzel, Y., Göbel, S., & Reichl, U.Shaking to very high cell densities - perfusion for virus productionPresented at: Kuhner Large Scale MeetingGirona (Spain), May 29, 2024.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yieldPresented at: 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI)Rio de Janeiro (Brazil), May 7, 2024.

Pelz, L., Rüdiger, D., Hein, M., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered defective interfering particles of influenza A virus for antiviral treatmentPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Dogra, T., Pelz, L., Boehme, J. D., Baelkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Exercise on vaccine designPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise.Presented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process IntensificationPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Development - From Master Seed to ProductionPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.